Does AMIVANTAMAB Cause Deep vein thrombosis? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Deep vein thrombosis have been filed in association with AMIVANTAMAB (Rybrevant). This represents 2.7% of all adverse event reports for AMIVANTAMAB.
20
Reports of Deep vein thrombosis with AMIVANTAMAB
2.7%
of all AMIVANTAMAB reports
1
Deaths
16
Hospitalizations
How Dangerous Is Deep vein thrombosis From AMIVANTAMAB?
Of the 20 reports, 1 (5.0%) resulted in death, 16 (80.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.
Is Deep vein thrombosis Listed in the Official Label?
Yes, Deep vein thrombosis is listed as a known adverse reaction in the official FDA drug label for AMIVANTAMAB.
What Other Side Effects Does AMIVANTAMAB Cause?
Infusion related reaction (62)
Rash (61)
Pulmonary embolism (41)
Dermatitis acneiform (34)
Thrombocytopenia (33)
Paronychia (29)
Diarrhoea (25)
Pneumonitis (24)
Dyspnoea (23)
Nausea (23)
What Other Drugs Cause Deep vein thrombosis?
LENALIDOMIDE (3,286)
RIVAROXABAN (3,180)
TESTOSTERONE (2,213)
APIXABAN (1,944)
ETHINYL ESTRADIOL\ETONOGESTREL (1,577)
RITUXIMAB (1,287)
METHOTREXATE (1,146)
DROSPIRENONE\ETHINYL ESTRADIOL (1,139)
DEXAMETHASONE (1,067)
ADALIMUMAB (1,056)
Which AMIVANTAMAB Alternatives Have Lower Deep vein thrombosis Risk?
AMIVANTAMAB vs AMIVANTAMAB-VMJW
AMIVANTAMAB vs AMLODIPINE
AMIVANTAMAB vs AMLODIPINE BESILATE
AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB vs AMLODIPINE\BENAZEPRIL